Strs Ohio Rubius Therapeutics, Inc. Transaction History

Strs Ohio

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 24, 2022	SELL	$9.68 - $17.74 $23,232 - $42,575	-2,400 Closed	0 $0
Q3 2021 Oct 22, 2021	SELL	$17.6 - $25.91 $63,360 - $93,276	-3,600 Reduced 60.0%	2,400 $42,000
Q2 2021 Jul 26, 2021	BUY	$22.26 - $28.43 $133,560 - $170,580	6,000 New	6,000 $146,000
Q2 2019 Jul 25, 2019	SELL	$13.5 - $19.94 $47,250 - $69,790	-3,500 Closed	0 $0
Q3 2018 Oct 19, 2018	BUY	$20.06 - $26.94 $70,210 - $94,290	3,500 New	3,500 $84,000

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.